CENTERS FOR MEDICARE & MEDICAID SERVICES

Bills and resolutions

Center for Medicare and Medicaid Innovation: require testing of incentive payments for behavioral health providers and certain other providers for adoption and use of certified electronic health record technology (see H.R. 7427), H4396 [6AP]

Dept. of HHS: conduct demonstration program to test providing preferential treatment under Medicare, Medicaid, and Children’s Health Insurance Program for certain drugs and biologicals manufactured in U.S. (see S. 3991), S1980 [5AP] (see H.R. 7400), H4190 [5AP]

——— provide certain adjustments to Medicare payment for durable medical equipment included in DMEPOS (Durable Medical Equipment, Prosthetics, Orthotics and Supplies) Competitive Bidding Program (see H.R. 6641), H1073 [8FE]

Health: disapprove Dept. of the Treasury and Centers for Medicare & Medicaid Services rule relative to Patient Protection and Affordable Care Act (see S.J. Res. 43), S1749 [23MR] (see H.J. Res. 79), H3863 [24MR]

——— increase interagency coordination to prevent and detect duplicate payments for medical services provided by VA, TRICARE, and Centers for Medicare & Medicaid Services (see H.R. 7275), H3970 [29MR]

——— provide for national public health education campaign, grant program, and task force for recommended preventive health care services during coronavirus pandemic and future pandemics (see H.R. 7617), H4607 [28AP]

Health care facilities: enhance compliance with hospital price transparency requirements (see S. 3749), S990 [3MR]

——— ensure nursing facilities report information on medical directors of such facilities and make such information available to public (see H.R. 8832), H7880 [15SE]

Health care professionals: authorize grants for graduate medical education partnerships in States with low ratio of medical residents relative to population (see H.R. 9424), H8757 [5DE]

——— extend Emergency Declaration Blanket Waiver beyond coronavirus emergency period relative to training and certification of nurse aides (see H.R. 7744), H4919 [12MY]

Insurance: provide guidance regarding coverage of prescription digital therapeutics under Medicaid and State Children’s Health Insurance Program (see S. 5238), S7101 [12DE]

Medicaid: support provision of treatment family care services (see S. 3761), S991 [3MR]

Medicare: extend Quality Payment Program-Small Practice, Underserved, and Rural Support program (see S. 3557), S496 [2FE] (see H.R. 6576), H917 [2FE]

——— provide review process for adverse national coverage determinations relative to drug coverage of certain new, innovative treatments (see H.R. 9358), H8647 [29NO]

——— remove physician certification requirement for inpatient critical access hospital services (see H.R. 6700), H1114 [9FE]

Medicare/Medicaid: improve access to care for beneficiaries through models tested under Center for Medicare & Medicaid Innovation (see S. 4067), S2092 [7AP] (see H.R. 7755), H4920 [12MY]

——— improve access to Program of All-Inclusive Care for the Elderly (see S. 3626), S646 [10FE] (see H.R. 6770), H1130 [18FE] (see H.R. 9209), H8408 [21OC]

Senior citizens: develop mobility metric to guide providers in preventing mobility loss among hospitalized older adults (see H. Res. 1177), H5610 [15JN]

States: provide guidance on furnishing behavioral health services and treatment under Medicaid and Children’s Health Insurance Program using telehealth services (see S. 4039), S2091 [7AP]

Technology: test effect of technology-enabled home care to coordinate care over time and across settings, improve quality, and lower costs for certain Medicare Advantage beneficiaries (see S. 3793), S1118 [10MR]

Motions

Government regulations: disapprove rule entitled ‘‘Medicare and Medicaid Programs; Omnibus COVID–19 Health Care Staff Vaccination’’ (S.J. Res. 32), S874 [1MR]

Remarks in House

Dept. of Veterans Affairs: call for Federal review of Wisconsin Veterans Home at Union Grove, H7080 [26JY]

Drugs: implement manufacturer discount program, H7702 [12AU]

FDA: provide for regulation of in-vitro clinical tests, H5320 [7JN]

——— provide for regulation of in-vitro clinical tests (H.R. 4128), H3785 [17MR]

Pharmaceuticals: decision to restrict coverage of Biogen, Inc., Alzheimer’s disease drug, H4577 [28AP]

Remarks in Senate

Children’s Health Insurance Program: impact, S2356 [5MY]

Government regulations: disapprove rule entitled ‘‘Medicare and Medicaid Programs; Omnibus COVID–19 Health Care Staff Vaccination’’ (S.J. Res. 32), S924, S933–S936 [2MR], S963 [3MR]

Texts of

S. 4039, Medicaid Ensuring Necessary Telehealth Is Available Long-term (MENTAL) Health for Kids and Underserved Act, S2095 [7AP]

S.J. Res. 32, disapprove Centers for Medicare & Medicaid Services rule entitled ‘‘Medicare and Medicaid Programs; Omnibus COVID–19 Health Care Staff Vaccination’’, S936 [2MR]